First report of anti-TIF1Î³ dermatomyositis in a patient with myelodysplastic syndrome.

Palterer, B; Vitiello, G; Cammelli, D

Palterer, B; Vitiello, G; Cammelli, D.

Affiliation

Palterer B; Experimental and Clinical Medicine Dept., University of Florence, Florence. boaz.palterer@gmail.com.

Reumatismo ; 69(2): 75-77, 2017 Aug 03.

Article in En | MEDLINE | ID: mdl-28776361

Subject(s)

Dermatomyositis/diagnosis; Dermatomyositis/etiology; Isoantibodies/blood; Myelodysplastic Syndromes/complications; Pneumonia, Aspiration/complications; Aged; Anemia, Megaloblastic/complications; Biomarkers/blood; Dermatologic Agents/therapeutic use; Dermatomyositis/blood; Dermatomyositis/drug therapy; Drug Therapy, Combination; Fatal Outcome; Female; Glucocorticoids/therapeutic use; Humans; Immunoglobulins/therapeutic use; Methotrexate/therapeutic use; Risk Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Pneumonia, Aspiration / Myelodysplastic Syndromes / Dermatomyositis / Isoantibodies Type of study: Etiology_studies / Risk_factors_studies Limits: Aged / Female / Humans Language: En Journal: Reumatismo Year: 2017 Document type: Article

Fulltext

XML

PubMed Links

Search on Google